Table 1.
Experimental designs for the anti-toxoplasmosis study using the mouse model

Group	T. gondii	Treatment	n
I		Vehicle	5
II	1 × 105/mouse	Vehicle	5
III	1 × 105/mouse	Sulfadiazine (50 mg/kg)	5
IV	1 × 105/mouse	Dictamnus dasycarpus (30 mg/kg)	5